InvestorsHub Logo

XenaLives

02/25/21 7:15 PM

#300654 RE: Jonjones325 #300653

I'm not sure an interim look at Alzheimer's is necessary.

Data could be in hand presently or within weeks.

bennyboy1

02/25/21 7:33 PM

#300656 RE: Jonjones325 #300653

Jonjones325: I sincerely hope Doc Missling is working on a "basket trial" approval for 2-73 armed with a great deal of data for Alzheimer's, Rett and Parkinson's! If it should happen, Doctors'would be able to write Off Label scripts! We are at the mercy of the FDA and TGA in Australia. SAFETY is a great 2-73 profile, and with efficacy should be a no-brainer!!